Partnership with Pfizer, Wyeth, Elan, and Johnson and Johnson, sounds like a lot potential here and this has been the topic since July, 2010, and also the stock started tanking at that time from 0.21 to where it is now. Somebody say it was because of dilution, is that true? and also the company issued millions of new shares, which will mature on April 23, 2011, another round of dilution? I am not negative about this stock. I wanna get things clarified before buying. thanks.